Executive readout · one minute
Call research workspace
Read the call alongside every captured source. 8-K earnings release, 10-K stay in one workspace.
VRTX
$522.81
-0.74%
VRTX
· Vertex Pharmaceuticals Inc / Ma
$522.81
-3.92 (-0.74%)
At close · Sep 30
Return incl. dividend (before tax)
Market Cap
$133.37B
Shares
253.46M
Volume · Sep 30
1.15M
Avg daily vol (3M)
1.23M
All earnings calls
Earnings call · FY2019 Q4
Vertex Pharmaceuticals Inc (VRTX) Q4 2019 Earnings Call
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Revenue
$1.41B
+62.4% YoY
Diluted EPS
$2.23
-62.6% YoY
Net income
$583.23M
-62.4% YoY
Research materials
Open the source you need; every reader stays inside this workspace.
Quarter detail
How the reported period landed and where the business moved.
SEC filing · Item 2.02
8-K earnings release
Filed Jan 30, 2020 · complete as-filed document
SEC periodic report
10-K report
Filed Feb 13, 2020 · complete as-filed document